Assessment of Bowel Perfusion Using Indocyanine Green Fluorescence Imaging during Laparoscopic Resection of Colorectal Cancer: A Randomized Controlled Trial

Key Takeaways for GI Nurses

• Indocyanine green (ICG) fluorescence imaging is being evaluated as a real-time assessment tool to visualize bowel perfusion during laparoscopic colorectal cancer resections, potentially reducing anastomotic complications
• This technology may help surgeons make more informed decisions about tissue viability at anastomotic sites, which could directly impact post-operative patient outcomes and recovery trajectories
• As perioperative nurses, understanding fluorescence-guided surgery techniques becomes increasingly important as these technologies integrate into standard colorectal surgical practice
• The randomized controlled trial design of this research provides high-quality evidence that may influence future surgical protocols and nursing care standards in colorectal cancer procedures

Clinical Relevance

This research has significant implications for GI nurses working in perioperative and post-operative settings. Anastomotic leaks remain one of the most serious complications following colorectal surgery, often requiring emergency interventions, prolonged hospitalizations, and intensive nursing care. If ICG fluorescence imaging proves effective in reducing these complications by ensuring adequate bowel perfusion before anastomosis creation, nurses can expect to see improved patient outcomes and potentially shorter recovery periods. This technology may also change the intraoperative workflow, requiring nurses to become familiar with fluorescence imaging equipment, ICG preparation and administration protocols, and the interpretation of perfusion assessments.

From a patient safety perspective, this innovation aligns with nursing priorities of preventing complications and optimizing surgical outcomes. Nurses involved in pre-operative education may need to counsel patients about ICG use, including potential allergic reactions and the temporary green discoloration of urine that occurs post-injection. Post-operatively, while the technology aims to reduce anastomotic complications, nurses must remain vigilant for signs of leak or perfusion issues, understanding that even advanced imaging techniques require careful clinical correlation and ongoing assessment.

The adoption of fluorescence-guided surgery also represents an opportunity for professional development within GI nursing. As minimally invasive techniques continue to evolve, nurses who understand these advanced technologies will be better positioned to provide comprehensive patient care, participate in quality improvement initiatives, and contribute to interdisciplinary discussions about surgical outcomes. This knowledge becomes particularly valuable when educating newer staff members or participating in protocol development for colorectal cancer care pathways.

Bottom Line

This randomized controlled trial examining ICG fluorescence imaging for bowel perfusion assessment represents a potentially practice-changing advancement in colorectal cancer surgery that could significantly reduce anastomotic complications – one of the most feared post-operative complications that GI nurses manage. Understanding this technology and its implications for patient care will be essential as it likely moves toward broader clinical adoption, making this research particularly relevant for nurses working in surgical gastroenterology settings who want to stay current with evidence-based innovations that directly impact patient outcomes.